You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

prostate cancer, abiraterone, apalutamide

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide acetate
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)

Recruiting
  • High-risk Prostate Cancer
  • Neoadjuvant Therapy
  • Abiraterone acetate
  • +4 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 6, 2022

Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Nov 21, 2023

Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Not yet recruiting
  • Metastatic Prostate Cancer
  • Castration-Sensitive Prostate Cancer
  • Shanghai, Shanghai, China
  • +1 more
Feb 4, 2023

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Abiraterone Acetate in Indian Metastatic, Castration Resistant

Withdrawn
  • Prostate Cancer
  • Abiraterone Acetate
  • Bangalore, India
  • +2 more
Aug 15, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

Active, not recruiting
  • Castration-Resistant Prostate Cancer
  • Greenville, South Carolina
  • +4 more
Aug 2, 2022

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) Trial (dalpiciclib isethionate tablets; abiraterone acetate

Not yet recruiting
  • High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
  • dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets
  • placebo; abiraterone acetate tablets; prednisone tablets
  • (no location specified)
Oct 20, 2023

Prostate Cancer Castration-resistant Prostate Cancer Trial in Changsha (Abiraterone+SHR3162)

Active, not recruiting
  • Prostate Cancer Castration-resistant Prostate Cancer
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Jul 6, 2022

Prostate Cancer, Biochemical Recurrence, High Risk Trial in Nanjing, Nantong (Apalutamide 60mg Tab, Androgen deprivation

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Apalutamide 60mg Tab
  • Androgen deprivation therapy(ADT)
  • Nanjing, Jiangsu, China
  • +2 more
Mar 17, 2023

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
Has Results
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Prostatic Tumors Trial in Canada, United States (Niraparib, Apalutamide, Abiraterone Acetate)

Completed
  • Prostatic Neoplasms
  • West Hollywood, California
  • +5 more
Jul 16, 2020

Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

Recruiting
  • Small Cell Neuroendocrine Carcinoma
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 21, 2022

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Dec 28, 2022

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Miami, Florida
  • +4 more
Dec 14, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

Recruiting
  • Neoadjuvant Therapy
  • Nanjing, Jiangsu, China
  • +2 more
Jan 3, 2023

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022